Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
"The results of the clinical trial conducted by Baxter are promising because the vaccine generated a potent human immune reaction, covered the complete range of Borrelia active in the entire Northern hemisphere, and produced no major side effects. We hope that a larger-scale, Phase 3 trial will demonstrate not only a strong immune response but true efficacy in a large population that illustrates protection against Lyme disease."
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
"Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial"
Nina Wressnigg PhD,Eva-Maria Pöllabauer MD,Gerald Aichinger MD,Daniel Portsmouth PhD,Alexandra Löw-Baselli PhD et. al
The Lancet Infectious Diseases, May 2013, doi:10.1016/S1473-3099(13)70110-5
Visit our Infectious Diseases / Bacteria / Viruses category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Fitzgerald, Kelly. "Potential Lyme Disease Vaccine Shows Promise." Medical News Today. MediLexicon, Intl., 14 May. 2013. Web.
23 Apr. 2014. <http://www.medicalnewstoday.com/articles/260471>
Fitzgerald, K. (2013, May 14). "Potential Lyme Disease Vaccine Shows Promise." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/260471.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.